Empirico
David Rozema is an experienced professional in the field of chemistry and biotechnology. Currently serving as an Honorary Fellow at the University of Wisconsin-Extension, David is involved in class development and teaching for the online Master's in Biotechnology program. Prior to this role, David held positions such as Head of Therapeutic Chemistry at Empirico Inc., Vice President of Chemistry at Arrowhead Pharmaceuticals, and Program Director at Roche Pharmaceuticals. With a Ph.D. in Chemistry from the University of Wisconsin-Madison and a background in postdoctoral research at the University of Utah, David has a solid educational foundation to support their career achievements in research and development within the pharmaceutical industry.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.